Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 981-985

  Mori, Yoichiro ^a   Ishiguro, Hideyuki ^a   Kuwabara, Yoshiyuki ^a   Kimura, Masahiro ^a   Mitsui, Akira ^a   Kurehara, Hiroki ^a   Mori, Ryota ^a   Tomoda, Keisuke ^a   Ogawa, Ryo ^a   Katada, Takeyasu ^a   Harata, Koshiro ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Esophageal cancer related gene 4; Esophageal squamous cell carcinoma; Quantitative RT PCR

Indexed keywords

C2ORF40 PROTEIN, HUMAN; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CANCER STAGING; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 38449122486     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.981     Document Type: Article

References (19)

1. Su T, Liu H and Lu S: Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 20: 254-257, 1998.
2. Hu N, Roth MJ, Polymeropolous M, et al: Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer 27: 217-228, 2000. (Pubitemid 30067450)
3. Wong DJ, Barrett MT, Stoger R, Emond MJ and Reid BJ: p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res 57: 2619-2622, 1997. (Pubitemid 27283770)
4. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M and Ishizaki K: Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58: 3429-3434, 1998. (Pubitemid 28371086)
5. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD and Yang CS: Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 5: 2704-2713, 1999. (Pubitemid 29493943)
6. Si HX, Tsao SW, Lam KY, et al: E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 173: 71-78, 2001. (Pubitemid 32907511)
7. Yue CM, Deng DJ, Bi MX, Guo LP and Lu SH: Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1174-1178, 2003.
8. Okawa T, Tanaka M, Kita M, et al: Radiotherapy for superficial esophageal cancer. Int J Radiat Oncol Biol Phys 30: 959-964, 1994. (Pubitemid 24355948)
9. Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M and Ishizaki K: Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg 226: 162-168, 1997. (Pubitemid 28047538)
10. Japanese Society for Esophageal Diseases: Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multi-institutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer. J Am Coll Surg 192: 708-718, 2001.
11. Kato J, Kuwabara Y, Mitani M, et al: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95, 2001. (Pubitemid 32187079)
12. Konishi S, Ishiguro H, Shibata Y, et al: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer 95: 2473-2478, 2002. (Pubitemid 35424031)
13. Shibata Y, Haruki N, Kuwabara Y, et al: Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 32: 233-237, 2002. (Pubitemid 43102805)
14. Shibata Y, Haruki N, Kuwabara Y, et al: Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 23: 1695-1699, 2002.
15. Terashita Y, Sasaki H, Haruki N, et al: Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32: 238-243, 2002. (Pubitemid 43102806)
16. Terashita Y, Ishiguro H, Haruki N, et al: Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep 12: 827-831, 2004.
17. Ando T, Ishiguro H, Kuwabara Y, et al: Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 15: 1551-1555, 2006.
18. Takashima N, Ishiguro H, Kuwabara Y, et al: Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep 15: 667-671, 2006.
19. Ando T, Ishiguro H, Kimura M, et al: Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 19: 454-458, 2006. (Pubitemid 44644681)